FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 28.4

Change

-0.61 (-2.10)%

Market Cap

N/A

Volume

0.22M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-27 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-2.80 (-2.18%)

USD 19.16B
VOT Vanguard Mid-Cap Growth Index ..

-4.00 (-1.54%)

USD 16.53B
IJK iShares S&P Mid-Cap 400 Growth..

-1.46 (-1.63%)

USD 9.61B
XMMO Invesco S&P MidCap Momentum ET..

-1.94 (-1.59%)

USD 4.68B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-2.01 (-1.81%)

USD 1.15B
CWS AdvisorShares Focused Equity E..

-0.40 (-0.60%)

USD 0.18B
ETHO Amplify ETF Trust

-1.01 (-1.71%)

USD 0.18B
IPO Renaissance IPO ETF

-1.52 (-3.52%)

USD 0.16B
BFOR Barron's 400 ETF

-0.92 (-1.27%)

USD 0.16B
PEXL Pacer US Export Leaders ETF

-1.13 (-2.30%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.66% 81% B- 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.66% 81% B- 33% F
Trailing 12 Months  
Capital Gain 3.39% 50% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.39% 50% F 34% F
Trailing 5 Years  
Capital Gain -12.35% 6% D- 30% F
Dividend Return 2.64% 17% F 6% D-
Total Return -9.70% 6% D- 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.25% 11% F 26% F
Dividend Return -0.56% 11% F 18% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 30.05% 22% F 35% F
Risk Adjusted Return -1.86% 11% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.